Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/11/1992 | EP0512400A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
11/11/1992 | EP0512399A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
11/11/1992 | EP0512352A2 Substituted carboxylic acid derivatives |
11/11/1992 | EP0512350A2 Indole derivatives |
11/11/1992 | EP0512349A1 Benzothiophene-2-carboxamide-S,S-dioxides |
11/11/1992 | EP0512343A2 Amino acid derivatives and their use as anti-viral agents |
11/11/1992 | EP0512107A1 Storage phosphor cassette assembly |
11/11/1992 | EP0512104A1 Stabilized hexahydro-5-pyrimidinamine compounds in aqueous solution and methods for preparing same |
11/11/1992 | EP0512095A1 Methyl pyrrolidinone chitosan, production process and uses thereof. |
11/11/1992 | EP0512076A1 Method of treating cancer using structured lipids |
11/11/1992 | EP0512050A1 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
11/11/1992 | EP0512024A1 Drugs and use thereof |
11/11/1992 | EP0409862B1 Topical preparations |
11/11/1992 | EP0345251B1 Pharmaceutical compositions for the treatment of cancers |
11/11/1992 | EP0305470B1 Antiinfective compounds and method of use |
11/11/1992 | EP0299975B1 Composition for arresting angiogenesis and capillary, cell or membrane leakage |
11/11/1992 | EP0298134B1 Aromatic heterocyclic carboxylic acid amide derivatives, process for their preparation, and pharmaceutical composition containing same |
11/11/1992 | EP0213129B1 New 9-halogen-prostaglandine |
11/11/1992 | CN1066072A 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz (cd) indoles |
11/11/1992 | CN1066071A 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd) indoles |
11/11/1992 | CN1066070A Benzo-fused lactams that promote release of growth hormone |
11/11/1992 | CN1066068A 4-aryl-3-(heteroarylureido) quinoline derivatives |
11/11/1992 | CN1066067A Thiazolidinone and oxazolidinone derivatives, their preparation and their use as vasodilators |
11/11/1992 | CN1066066A Z-aminopyrimidine-4-formamide derivatives, process for preparing same and use in therapy |
11/11/1992 | CN1066065A Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments |
11/11/1992 | CN1066062A Pharmaceutical compound |
11/11/1992 | CN1066060A Pharmaceutical compound |
11/11/1992 | CN1065994A Marrow scavenger and its preparation method |
11/11/1992 | CN1065993A Preparation method of synergistic antimalarial compound benzfluorenol |
11/11/1992 | CN1065978A Technique for stimulating appetite of livestock and poultry |
11/11/1992 | CN1019012B Process for producing 1-substituted aryl-1, 4-dihydro-4-oxonaphthyridine derivative intermediates |
11/11/1992 | CN1019010B Process for preparing substituted beta-diketones |
11/11/1992 | CA2109524A1 Acidic aralkyl triazole derivatives active as angiotensin ii antagonists |
11/11/1992 | CA2109205A1 Methods and compositions for inhibiting deposit formation on contact lenses |
11/11/1992 | CA2102804A1 3'-end blocked oligonucleotides |
11/11/1992 | CA2102802A1 Substituted 1-(2h)-isoquinolinones bearing acidic functional groups as angiotensin ii antagonists |
11/11/1992 | CA2068366A1 Microcapsule composition and process |
11/11/1992 | CA2068292A1 New 2-piperazinylbenzimidazole derivatives |
11/11/1992 | CA2068261A1 Urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
11/11/1992 | CA2068238A1 Indole derivatives |
11/11/1992 | CA2068229A1 Substituted quinazolinones bearing acidic functional groups as angiotensin ii antagonists |
11/10/1992 | US5162581 Antitumor and immunosuppressive agents |
11/10/1992 | US5162573 Anticonvulsant, antiepileptic agent |
11/10/1992 | US5162569 Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives |
11/10/1992 | US5162543 Hypotensive agents |
11/10/1992 | US5162538 Antiviral new peptides |
11/10/1992 | US5162533 3-cyano-5,4'-bipyridine-1'-oxide compounds and pharmaceutical compositions and methods containing the same |
11/10/1992 | US5162532 Intermediates and method of making camptothecin and camptothecin analogs |
11/10/1992 | US5162523 Cephalosporin antibacterial compounds |
11/10/1992 | US5162522 Method for producing cephem compounds |
11/10/1992 | US5162520 Intermediates for cephem compounds |
11/10/1992 | US5162515 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
11/10/1992 | US5162512 Treatment of cellular disorders |
11/10/1992 | US5162375 8-Hydroxy-2-/Dipropylamino/Tetralin |
11/10/1992 | US5162374 Method for reversibly arresting muscle activity |
11/10/1992 | US5162372 Diester-diamide-diamine |
11/10/1992 | US5162371 Method for treating inflammation |
11/10/1992 | US5162370 Treatment of cataract with prostacyclin compounds |
11/10/1992 | US5162369 Composition and method for enhancing the immune system in warm-blooded animals exhibiting symptoms of antigenic morbidity |
11/10/1992 | US5162368 Butalactin and its use as pharmaceutical |
11/10/1992 | US5162366 Antioxidant composition in vivo comprising enol form δ-lactone of diketogulonic acid |
11/10/1992 | US5162365 5-lipoxygenase inhibitors |
11/10/1992 | US5162364 4-aminobutyric acid compounds, compositions, and method of use for treating disorders related to a dysfunction of gabab receptors |
11/10/1992 | US5162361 Method of treating diseases associated with elevated levels of interleukin 1 |
11/10/1992 | US5162359 Antihyperlipoproteinemic 5-benzyl substituted-benzimidazoline-2-thion derivatives |
11/10/1992 | US5162356 Azole mycocide and method of treating mycosis |
11/10/1992 | US5162350 Benzothiazolinone compounds |
11/10/1992 | US5162346 Pharmaceutical composition comprising flupirtine and its use to combat muscular tension |
11/10/1992 | US5162345 Heterocyclic compounds and their preparation and pharmaceutical formulation |
11/10/1992 | US5162341 Use of sigma receptor antagonists for treatment of amphetamine abuse |
11/10/1992 | US5162340 Hypotensive agents, treatment of congestive heart failure |
11/10/1992 | US5162339 Substance P Antagonists, Gastrointestinal and Central Nervous System Disorders, Antiinflammatory Agents, Analgesics |
11/10/1992 | US5162337 Animal growth promotion |
11/10/1992 | US5162335 Di- and tetrahydroisoquinoline derivatives |
11/10/1992 | US5162330 Dynemicin c antibiotic, its triacetyl derivative and pharmaceutical composition containing same |
11/10/1992 | US5162328 N-[3-[2-(1H-imidazol-1-yl)ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts |
11/10/1992 | US5162325 Angiotensin ii antagonists incorporating a substituted benzyl element |
11/10/1992 | US5162323 Inhibition of the withdrawal syndrome |
11/10/1992 | US5162322 Anxiolytic agetns; humans, animals |
11/10/1992 | US5162320 1,4-bis(alkylamino)-2,3-diaza-anthracene-9,10-diones |
11/10/1992 | US5162316 Pyrimido[4,5-d]pyrimidine derivatives for use as bronchodilators |
11/10/1992 | US5162313 Control of heme and iron concentrations in body tissues |
11/10/1992 | US5162312 11β-substituted 16α, 17α-methylene-estra-4,9-dien-3-ones |
11/10/1992 | US5162311 Treating epilepsy, psychiatric disorders |
11/10/1992 | US5162310 Calcium Metabolism Regulators |
11/10/1992 | US5162309 Mono (2-ammonium-2-hydroxymethyl-1,3-propanediol)(2r,cis)-1,2-ep-oxipropyl-phosphonate with improved characteristics of stability and processing |
11/10/1992 | US5162304 Pharmaceutical compositions and methods for treatment and prophylaxis of cancer |
11/10/1992 | US5162302 Thyroid Hormone, Growth Hormone Releasing Factor or Thyrotropin Releasing Hormone |
11/10/1992 | US5162231 Method of using 5,10,15,20-tetrakis(carboxyphenyl)porphine for detecting cancers of the lung |
11/10/1992 | US5162198 Method of using dehydroepiandrosterone and dehydroepiandrosterone-sulfate as inhibitors of thrombuxane production and platelet aggregation |
11/10/1992 | US5162117 Controlled release flutamide composition |
11/10/1992 | US5162115 Antineoplastic solution and method for treating neoplasms |
11/10/1992 | US5162110 Sustained release composition |
11/10/1992 | CA2068076A1 Substituted carboxylic acid derivaties |
11/10/1992 | CA2067567A1 Compounds |
11/10/1992 | CA2067537A1 Compounds |
11/10/1992 | CA2042167A1 Method of treatment of psychotic disorders |
11/10/1992 | CA1310020C 1-aminophenyl-2-dimethylaminopropanone derivatives, method of preparation and use in therapy |
11/10/1992 | CA1310017C Process for the preparation of 2, 6-dichlorodiphenylamino-acetic acid derivatives |
11/10/1992 | CA1310011C 1,4-dihydropyridine derivatives having a nitrogen containing heteroaryl group linked to the two position possessing antihypertensive and antithrombotic activity |